EUVIMEDEUVIMED entdecken
Crossref

A Self‐Homing Liposomal Nanobot for Active Therapy of Glioblastoma

Yanfang Cheng, Kangning Zhu, Ling Yang, Meng Mao, Yingjie Wu, Mingjun Xuan, Qiang He iD

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202512948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Yanfang Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Harbin Institute of Technology, Xidazhi Street 92, Harbin, 150001, China. Hauptthemen laut MEDLINE: Glioblastoma, Liposomes, Antineoplastic Agents, Brain Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Key R&D Program of Heilongjiang Province, China, China Postdoctoral Science Foundation, Postdoctoral Fellowship Program of CPSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) remains a substantial obstacle in therapy since the blood–brain barrier (BBB) and tumor microenvironment (TME) severely prevent the access of most exogenous therapeutic agents to the central nervous system. Overcoming this dual defense established by BBB‐TME is a critical challenge in GBM therapy. Here, we present a glucose oxidase (GOD)‐powered liposomal nanobot (lipoNbot) to breach the BBB‐TME through self‐homing navigation guided by the acid and glucose in TME—a mechanism rooted in the regulation of GOD activity, with optimal performance in acidic environments to actively deliver drugs for GBM chemotherapy. The lipoNbot features an asymmetric structure composed of GOD‐modified cancer cell membranes and γ‐glutamylated lipids, which synergistically enhance BBB‐TME penetration through chemotactic diffusiophoresis and γ‐glutamyl transferase (GGT)‐mediated transcytosis. The proton sponge effect facilitates lysosomal escape for BBB traversal. In vivo investigation indicates that lipoNbots achieve a 4.3‐fold increase in delivery efficiency. Such a lipoNbot poses the specific biochemical cues of GBM for self‐homing navigation, establishing a proof‐of‐concept framework utilizing the pathological features for active therapy of central nervous system diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaLiposomesAntineoplastic AgentsBrain NeoplasmsNanoparticlesHumansAnimalsBlood-Brain BarrierTumor MicroenvironmentMiceGlucose OxidaseCell Line, Tumor

Stichwörter der Autor:innen

Active therapyBlood–brain barrierNanobotSelf‐homingTumor microenvironment

Substanzen

LiposomesAntineoplastic AgentsGlucose Oxidase

Autor:innen und Institutionen

  • School of Medicine and Health, Harbin Institute of Technology, Xidazhi Street 92, Harbin, 150001, China.
  • Wenzhou Institute, University of Chinese Academy of Sciences, Jinlian Road 1, Wenzhou, 325000, China.

ORCID-Profile: Qiang He

Förderung

  • Key R&D Program of Heilongjiang Province, China
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of CPSF
  • Wenzhou Institute, University of Chinese Academy of Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Cheng, Y., Zhu, K., Yang, L., Mao, M., Wu, Y., Xuan, M., & He, Q. (2025). A Self‐Homing Liposomal Nanobot for Active Therapy of Glioblastoma. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202512948

Vancouver

Cheng Y, Zhu K, Yang L, Mao M, Wu Y, Xuan M, et al. A Self‐Homing Liposomal Nanobot for Active Therapy of Glioblastoma. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202512948

BibTeX
@article{Cheng2025,
  author = {Cheng, Yanfang and Zhu, Kangning and Yang, Ling and Mao, Meng and Wu, Yingjie and Xuan, Mingjun and He, Qiang},
  title = {A Self‐Homing Liposomal Nanobot for Active Therapy of Glioblastoma},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202512948}
}
Kostenlos starten →